BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25061176)

  • 1. The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.
    Glavey SV; Manier S; Natoni A; Sacco A; Moschetta M; Reagan MR; Murillo LS; Sahin I; Wu P; Mishima Y; Zhang Y; Zhang W; Zhang Y; Morgan G; Joshi L; Roccaro AM; Ghobrial IM; O'Dwyer ME
    Blood; 2014 Sep; 124(11):1765-76. PubMed ID: 25061176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of alpha2,6 sialylation during myeloid maturation: a potential role in myeloid cell release from the bone marrow.
    Le Marer N; Skacel PO
    J Cell Physiol; 1999 Jun; 179(3):315-24. PubMed ID: 10228950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the α2,3-sialylation of target proteins.
    Qi F; Isaji T; Duan C; Yang J; Wang Y; Fukuda T; Gu J
    FASEB J; 2020 Jan; 34(1):881-897. PubMed ID: 31914669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA ST3GAL6‑AS1 promotes invasion by inhibiting hnRNPA2B1‑mediated ST3GAL6 expression in multiple myeloma.
    Shen Y; Feng Y; Li F; Jia Y; Peng Y; Zhao W; Hu J; He A
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
    Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialyltransferase ST3GAL6 silencing reduces α2,3-sialylated glycans to regulate autophagy by decreasing HSPB8-BAG3 in the brain with hepatic encephalopathy.
    Li X; Xiao Y; Li P; Zhu Y; Guo Y; Bian H; Li Z
    J Zhejiang Univ Sci B; 2024 May; 25(6):485-498. PubMed ID: 38910494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
    Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
    Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
    Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
    Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.
    Pérez-Garay M; Arteta B; Pagès L; de Llorens R; de Bolòs C; Vidal-Vanaclocha F; Peracaula R
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
    Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy.
    Cohen AM; Allalouf D; Bessler H; Djaldetti M; Malachi T; Levinsky H
    Eur J Haematol; 1989 Mar; 42(3):289-92. PubMed ID: 2924892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.
    Purushothaman A; Toole BP
    J Biol Chem; 2014 Feb; 289(9):5499-509. PubMed ID: 24403068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model.
    Natoni A; Farrell ML; Harris S; Falank C; Kirkham-McCarthy L; Macauley MS; Reagan MR; O'Dwyer M
    Haematologica; 2020; 105(2):457-467. PubMed ID: 31101754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.
    Chachadi VB; Cheng H; Klinkebiel D; Christman JK; Cheng PW
    Int J Biochem Cell Biol; 2011 Apr; 43(4):586-93. PubMed ID: 21168523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
    Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
    Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.
    Yang WH; Nussbaum C; Grewal PK; Marth JD; Sperandio M
    Blood; 2012 Aug; 120(5):1015-26. PubMed ID: 22700726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.
    Kroes RA; He H; Emmett MR; Nilsson CL; Leach FE; Amster IJ; Marshall AG; Moskal JR
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12646-51. PubMed ID: 20616019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway.
    Sun M; Zhao X; Liang L; Pan X; Lv H; Zhao Y
    Cancer Sci; 2017 Feb; 108(2):267-276. PubMed ID: 27906498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
    Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
    Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.